SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (16276)9/14/2003 11:37:27 PM
From: Cacaito  Read Replies (4) | Respond to of 17367
 
Embrel already is selling $1 billion, forget their lawsuits, they have money to pay.

My worry is, with only $15M in sales for 2004, how is xoma going to pay for their lawsuits, when a massive bleeding or a lymphoproliferative disorder comes to a hospital near you!

They should put bpi on each Rap vial, to prevent the increase in infections with the Rap!



To: Bluegreen who wrote (16276)9/15/2003 2:44:31 PM
From: Arthur Radley  Respond to of 17367
 
Why don't you guys gang up on me and beat me up? I tired of seeing XOMA's stock price being the only thing beaten up...Hard to find a biotech with a drug approval just around the corner after the FDA panel approval and the stock taken out to the woodshed for a "whupping".


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News